| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $225K | — | — |
| R&D Expense | $1.4M | — | +0.8% |
| SG&A Expense | $1.2M | — | +23.3% |
| Operating Income | -$2.4M | — | -0.6% |
| Income Tax | $0 | — | — |
| Net Income | -$2.3M | — | +0.1% |
| EPS (Basic) | -$0.17 | — | +26.1% |
| EPS (Diluted) | -$0.17 | — | +26.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $5.9M | -27.0% | -32.7% |
| Total Assets | $7.4M | -23.5% | -30.3% |
| Current Liabilities | $2.2M | +0.9% | +15.4% |
| Total Liabilities | $3.3M | -2.1% | -1.3% |
| Stockholders' Equity | $4.1M | -35.0% | -43.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.3M | — | +20.4% |